ECB Rate Path May Deepen Stagflation Risks Berenberg Economist Warns Estate Transparency Crisis Sister Refuses to Explain Control of Mothers Assets Huawei Unveils New Chip Design Approach Amid US Restrictions Intensifying Tech Rivalry HELOC Rates Remain Low but Fed Rate Hike Expectations Could Shift the Landscape Telecom CEO Warns Europe Faces Strategic Vulnerability to US Satellite and AI Dominance Intel Pushes PC Makers Toward 18A Chips as AI Demand Surges Margin Boost Potential RELX Q2 2025 Earnings Narrow EPS Beat with Slight Stock Decline PLX Q1 2026 Earnings Massive EPS Surprise Drives Stock Higher Ascent Solar Technologies Inc ASTI Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Elusive Sunrun RUN Q1 2026 Earnings Solar Leader Posts Record EPS Surprise Shares Rally SAY Q1 2026 Earnings Significant Earnings Miss with Negative EPS LyondellBasell LYB Q1 2026 Earnings Surprise EPS Beat Fails to Lift Shares as Market Focuses on Demand Concerns FGI Industries Surges Over 7 as Positive Momentum Builds AEye Inc Warrant LIDRW Surges 10 but Holds at Key Support Analysis of Recent Activity Tyson Foods TSN Holds Steady Near Support Despite Modest Uptick MEDIROM Healthcare Technologies MRM Surges 30 Key Levels and Potential Drivers OXSQH Edges Higher as Bond Investors Assess Rate Path and Credit Stability US Charges Google Engineer with Insider Trading on Polymarket Prediction Platform Amicus Therapeutics Q4 2025 Earnings EPS Misses Expectations by a Wide Margin Incannex Healthcare IXHL Slips 455 as Biotech Selling Pressure Persists FFWM Q4 2025 Earnings EPS Significantly Misses Estimates Stock Rises 243 PDEX Q1 2026 Earnings EPS Surges 8975 Above Estimates Amid Stock Decline AVB Q1 2026 Earnings EPS Surpasses Estimates by 81 Amid Stable Multifamily Demand BMA Q4 2025 Earnings Strong EPS Beat Amidst Mixed Market Reaction SPCE Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Surge NTZ Q4 2011 Earnings Significant EPS Miss as Company Reports WiderthanExpected Loss PYPD Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances